Presentation of the Nephrology Quiz and Questionnaire (NQQ)
Transplantation Case 1: Donald E. HricikA 63-year-old woman with ESRD secondary to type 2 diabetes mellitus received a kidney transplant from a deceased donor 6 months ago. The donor was serologically positive for Epstein Barr-virus (EBV) and for cytomegalovirus (CMV) based on IgG titers, while the recipient was serologically negative for both EBV and CMV. The patient received induction antibody therapy with rabbit anti-thymocyte globulin (total dose ϳ 6 mg/kg) and maintenance therapy with tacrolimus, enteric-coated mycophenolate sodium, and glucocorticoids that were withdrawn per protocol after 7 days. At the time of transplantation, the following prophylactic agents were prescribed: trimethoprim-sulfamethoxazole (one single strength daily for life), co-trimazole troches (10 mg three times daily for 3 months), and valganciclovir (450 mg daily for 3 months